Cargando...
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
OBJECTIVE: Vortioxetine is a novel antidepressant approved for the treatment of major depressive disorder by the US Food and Drug Administration in September 2013. This meta-analysis assessed the efficacy and safety of different doses of vortioxetine for generalized anxiety disorder of adults. METHO...
Gardado en:
| Publicado en: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844447/ https://ncbi.nlm.nih.gov/pubmed/27143896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S104050 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|